Plain-English translation of NCT06708845 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Lupus Nephritis research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing a new treatment called Zamto-cel, which uses your own immune cells that have been engineered in a laboratory to fight autoimmune diseases like lupus and systemic sclerosis. Your cells are collected, modified to recognize and target specific disease-causing cells, and then returned to your body through an infusion. The study will carefully monitor your safety and how well the treatment works over one year.
Many people with severe lupus or systemic sclerosis don't respond well enough to current standard treatments, leaving them with ongoing pain, organ damage, and poor quality of life. Researchers believe this medication—which harnesses your own immune system in a new way—may help people whose disease has become resistant to other therapies.
You likely qualify if…
You likely don't qualify if…
You will first undergo a procedure to collect some of your immune cells (a process called leukapheresis). Before receiving the engineered cells, you'll be given chemotherapy drugs to prepare your immune system. Then you'll receive an intravenous infusion of your modified cells. You'll return for regular clinic visits and blood tests over one year to monitor for side effects and track whether the treatment is helping your disease, with longer-term follow-up continuing under a separate protocol.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
United States